Recurrence of colorectal carcinoma at the site of anastomosis is a common clinical problem, although its reported incidence varies widely between 10-48% . "' Some early recurrences represent inadequate excision of the primary tumour or adjacent lymphatics, and others could follow the implantation of viable carcinoma cells on the suture line.5 For 'recurrent' cancer arising two years or more after primary resection, however, metachronous carcinogenesis at the anastomosis seems a more likely explanation. Multiple colorectal carcinomas are known to occur in at least 3% of patients,2 and adenomas coexist with carcinoma in some 22% of cases. 6 Previous work from this laboratory and elsewhere has shown a high incidence of tumours in the immediate vicinity of a large bowel anastomosis in rats receiving azoxymethane or dimethylhydrazine.7 As this phenomenon occurs whether carcinogen treatment immediately precedes or follows transec-bility of the epithelium around the anastomosis may play an important role.
The present study was designed to investigate the relationship between the proliferative status of the mucosa and the susceptibility of an anastomosis to increased tumour development. Our data suggest that even healed anastomoses are preferential sites for colorectal carcinogenesis.
Methods EXPERIMENTAL DESIGN
Young, male Sprague-Dawley rats (N=234) weighing approximately 200 g were allocated to one of five experimental groups (Fig. 1) 7 8 Tumours per rat (n) Tumours per rat (n) (Fig. 2) . While most rats with sham transection developed one colonic tumour only, those with transection developed at least two. As previously observed,' most tumours arose on the left side of the colon irrespective of the type of operation (Figs 3 and 4) . Among shams, tumour yields in rats receiving azoxymethane from the day of operation (mean 2-1 tumours per rat) were approximately twice those in rats in which carcinogen administration was delayed (0-7-1-1).
In rats receiving transection of the lower left colon a substantial proportion of tumours was associated with the suture line at each time period: 23/48 when azoxymethane was received on the day of operation, 12/18 at two weeks, 25/38 at 4 weeks, 18/32 at eight weeks and 11/26 at 12 weeks. As seen in the shams, mean tumour yields were again higher when azoxymethane was started on the day of operation (mean 3-0 tumours per rat) than when carcinogen administration was delayed (1-2-2.4). In both shams and rats with transection approximately half the colonic tumours were adenomas and half were adenocarcinomas. Likewise, anastomotic tumours were equally distributed between benign and malignant neoplasms in each group. Four rats developed granulomas in response to the marker stitch placed on the serosal side of the colon.
EFFECT OF HEALING ON ANASTOMOTIC TUMOUR YIELDS
Histological sections taken through the anastomosis show that re-epithelialisation of colonic epithelium is complete at 12 weeks following transection of the bowel (Fig. 5) .
To determine whether increased healing of the anastomosis influenced its susceptibility to carcinogenesis, the individual effects of transection and timing of carcinogen administration were analysed both for total colorectal tumours and for extra anastomotic tumours. A generalised linear model with Poisson errors was fitted to the tumour data (Fig. 6) . Timing of carcinogen administration had a clear effect on both total and extra anastomotic tumour yields irrespective of transection, suggesting that susceptibility to azoxymethane decreased with age. Because colonic transection affected total tumour yields only and showed no interaction with time, the anastomosis was at greater risk of tumour development than intact mucosa elsewhere in the colon throughout the period of healing. At each time point after transection, the predicted increase in tumours arising at the anastomosis was constant at 77%. (Fig. 7) and labelling index (Fig. 8) The large yield of tumours at the suture line is in agreement with the findings of previous studies with colonic transection,7 partial colectomy,7 small bowel resection8 " and pancreaticobiliary diversion." In all these studies carcinogen was administered either before the operation or immediately thereafter. It is therefore of interest that a 12 week anastomosis remains at greater risk of tumour development than mucosa elsewhere in the colon, despite a return to normal histological appearances.
By contrast, the general susceptibility to develop tumours throughout the colon was found to decrease with increasing time periods before carcinogen administration, independent of whether rats received transection or handling of the bowel. Perhaps postoperative hyperaemia delivers greater concentrations of the ultimate carcinogen to the large intestine; alternatively older rats are less susceptible to the carcinogen.'2 Whatever the reason, the anastomosis is at an increased risk of carcinogenesis at each time point of healing. The development of anastomotic tumours has been attributed to the continued presence of suture material, acting as a chronic irritant. A suture placed in the rat caecum leads to increased thymidine uptake by adjacent epithelial cells and promotes local carcinogenesis.'3 In man, microscopic examination of anastomotic recurrence showed intramucosal fibrosis, non-specific chronic inflammation and a foreign body granulomatous reaction to suture material in addition to the focus of adenocarcinoma. 4 Despite using a non-absorbable suture material (silk), we seldom observed a chronic inflammatory response on the mucosal aspect of the healed anastomosis. More often we saw foreign body granulomatous reaction in the adventitia in response to the marker stitch placed on the serosal aspect of the colon. Furthermore the incidence of suture line cancer in rats is not affected by using absorbable or non-absorbable sutures. 5 16 A more plausible explanation for the development of anastomotic tumours in our experimental system is the selective action of azoxymethane on rapidly dividing crypt cells. In support, crypts in the immediate vicinity of the anastomosis retain a higher proliferative activity even after returning to a normal histological appearance. Stimulated crypt cell proliferation near the site of an anastomosis has been reported after transection of both small bowel'" and transverse colon.'8 Whereas Barkla and Tutton detected an increase in colonic crypt cell proliferation at four weeks only, we have found that the response persists for three months (although diminishing progressively). Stem cells are believed to be the target for the transforming effect of carcinogens,"'2 and these are presumably present in greater numbers during the spurt of proliferative activity that accompanies anastomotic healing.
The clinical implications of these findings are unclear. Clearly reparative hyperplasia is necessary to ensure safe healing of the anastomosis and should not be disturbed. Other situations in which increased cell proliferation potentiates carcinogenesis include chronic ulcerative proctocolitis,2'23 ureterosigmoidostomy undertaken for benign or malignant 
